Free Trial

ALX Oncology (ALXO) News Today

ALX Oncology logo
$1.74 +0.11 (+6.75%)
As of 01/17/2025 04:00 PM Eastern
ALX Oncology launches new equity incentive plan
ALX Oncology Adopts 2025 Inducement Equity Plan
ALX Oncology Holdings Inc. stock logo
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Short Interest Update
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) saw a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 7,600,000 shares, a drop of 9.4% from the December 15th total of 8,390,000 shares. Based on an average trading volume of 984,300 shares, the days-to-cover ratio is currently 7.7 days. Currently, 24.6% of the shares of the company are sold short.
ALX Oncology Holdings Inc. stock logo
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of "Moderate Buy" by Brokerages
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six ratings firms that are currently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation and three have assigned a
ALX Oncology Holdings Inc. stock logo
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Insider Jaume Pons Sells 10,796 Shares
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) insider Jaume Pons sold 10,796 shares of the stock in a transaction that occurred on Monday, December 30th. The shares were sold at an average price of $1.58, for a total value of $17,057.68. Following the completion of the sale, the insider now directly owns 580,714 shares of the company's stock, valued at $917,528.12. The trade was a 1.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
ALX Oncology Holdings Inc. stock logo
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Sees Large Increase in Short Interest
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 8,390,000 shares, a growth of 17.0% from the November 30th total of 7,170,000 shares. Currently, 24.4% of the shares of the company are sold short. Based on an average trading volume of 937,300 shares, the short-interest ratio is currently 9.0 days.
ALX Oncology Holdings Inc. stock logo
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Rating of "Moderate Buy" from Analysts
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) has received an average recommendation of "Moderate Buy" from the six analysts that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and three have given a
ALX Oncology Holdings Inc. stock logo
Jefferies Financial Group Downgrades ALX Oncology (NASDAQ:ALXO) to Hold
Jefferies Financial Group lowered ALX Oncology from a "buy" rating to a "hold" rating and reduced their target price for the company from $12.00 to $2.00 in a report on Thursday.
ALX Oncology to present updated results from Phase 2 ASPEN-06 trial
ALX Oncology Holdings Inc. stock logo
ALX Oncology (NASDAQ:ALXO) Earns "Overweight" Rating from Cantor Fitzgerald
Cantor Fitzgerald reiterated an "overweight" rating on shares of ALX Oncology in a report on Wednesday.
ALX Oncology Holdings Inc. stock logo
HC Wainwright Reiterates Buy Rating for ALX Oncology (NASDAQ:ALXO)
HC Wainwright restated a "buy" rating and set a $25.00 price objective on shares of ALX Oncology in a research report on Wednesday.
ALX Oncology Holdings (ALXO) Gets a Hold from LifeSci Capital
ALX Oncology to host virtual event to discuss Phase 1b/2 evorpacept data
ALX Oncology Holdings Inc. stock logo
Fmr LLC Sells 1,949,890 Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO)
Fmr LLC cut its position in ALX Oncology Holdings Inc. (NASDAQ:ALXO - Free Report) by 25.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,865,106 shares of the company's stock after selling 1,9
ALX Oncology Holdings Inc. stock logo
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) have been assigned an average rating of "Moderate Buy" from the six ratings firms that are presently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and four have assigned
ALX Oncology Holdings Inc. stock logo
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) have been given a consensus rating of "Moderate Buy" by the six research firms that are currently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and four have given a
ALX Oncology Holdings Inc. stock logo
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Sees Significant Decrease in Short Interest
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) was the recipient of a large decrease in short interest in October. As of October 31st, there was short interest totalling 7,840,000 shares, a decrease of 18.2% from the October 15th total of 9,590,000 shares. Currently, 25.9% of the shares of the stock are sold short. Based on an average daily volume of 701,400 shares, the days-to-cover ratio is presently 11.2 days.
ALX Oncology Holdings Inc. stock logo
Cantor Fitzgerald Comments on ALX Oncology FY2024 Earnings
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Free Report) - Stock analysts at Cantor Fitzgerald raised their FY2024 earnings per share estimates for ALX Oncology in a report released on Tuesday, November 12th. Cantor Fitzgerald analyst L. Watsek now forecasts that the company will post earnings per
ALX Oncology appoints Alan Sandler as CMO
ALX Oncology Strengthens Leadership with Key Appointment
ALX Oncology Holdings Inc. stock logo
Cantor Fitzgerald Reiterates Overweight Rating for ALX Oncology (NASDAQ:ALXO)
Cantor Fitzgerald reissued an "overweight" rating on shares of ALX Oncology in a research report on Tuesday.
ALX Oncology Holdings Inc. stock logo
Analysts Offer Predictions for ALX Oncology FY2028 Earnings
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Free Report) - Research analysts at HC Wainwright lowered their FY2028 earnings estimates for ALX Oncology in a report released on Friday, November 8th. HC Wainwright analyst S. Ramakanth now forecasts that the company will earn $1.43 per share for the ye
ALX Oncology reports Q3 EPS (58c) consensus (78c)
ALX Oncology Holdings Inc. stock logo
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of "Moderate Buy" by Analysts
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the six analysts that are covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and four have assigned a buy recomme
ALX Oncology Holdings Inc. stock logo
Short Interest in ALX Oncology Holdings Inc. (NASDAQ:ALXO) Declines By 6.7%
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) was the recipient of a large decline in short interest during the month of September. As of September 30th, there was short interest totalling 9,320,000 shares, a decline of 6.7% from the September 15th total of 9,990,000 shares. Approximately 30.9% of the company's stock are short sold. Based on an average daily trading volume, of 1,150,000 shares, the short-interest ratio is presently 8.1 days.
Aurora lightshow continues into the weekend across Canada
ALX Oncology Holdings Inc. stock logo
Point72 Asset Management L.P. Makes New $1.83 Million Investment in ALX Oncology Holdings Inc. (NASDAQ:ALXO)
Point72 Asset Management L.P. acquired a new position in shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO - Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The fund acquired 304,100 shares of the company's stock, valued at approximately $1,834,000. Point72 Asset
ALX Oncology Holdings Inc. stock logo
Marshall Wace LLP Has $3.83 Million Stake in ALX Oncology Holdings Inc. (NASDAQ:ALXO)
Marshall Wace LLP increased its stake in ALX Oncology Holdings Inc. (NASDAQ:ALXO - Free Report) by 423.0% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 635,679 shares of the company's stock after acquirin
Investors Balance Rate Elation Against Economic Worries
ALX Oncology Holdings Inc. stock logo
396,966 Shares in ALX Oncology Holdings Inc. (NASDAQ:ALXO) Acquired by Privium Fund Management B.V.
Privium Fund Management B.V. bought a new position in shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 396,966 shares of the company's stock,
ALX Oncology Holdings Inc. stock logo
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Average Rating of "Moderate Buy" from Analysts
Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) have earned an average recommendation of "Moderate Buy" from the seven ratings firms that are currently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and five have a
ALX Oncology Holdings Inc. stock logo
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Sees Significant Growth in Short Interest
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) was the target of a significant increase in short interest during the month of July. As of July 31st, there was short interest totalling 9,080,000 shares, an increase of 17.2% from the July 15th total of 7,750,000 shares. Based on an average daily volume of 1,280,000 shares, the days-to-cover ratio is presently 7.1 days. Approximately 30.5% of the company's shares are short sold.
Get ALX Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALXO and its competitors with MarketBeat's FREE daily newsletter.

ALXO Media Mentions By Week

ALXO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ALXO
News Sentiment

1.03

0.46

Average
Medical
News Sentiment

ALXO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ALXO Articles
This Week

4

3

ALXO Articles
Average Week

Get ALX Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALXO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ALXO) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners